The Medical Device Business Journal — Medical Device News & Articles | MassDevice
William Caldwell IV, the chairman and CEO of Advanced Cell Technology Inc. (OTC:ACTC), died suddenly Dec. 13. He was 63.
Marlborough, Mass.-based ACT said Caldwell had been CEO since 2005 and chairman since 2006.
Just a day after Eden Prairie, Minn.-based SurModics Inc. (NSDQ:SRDX), said it would formally respond to Ramius LLC’s efforts to name three people to its board of directors, the company announced it had named a new CEO and would explore a sale of its pharmaceuticals business.
Former national security advisor Gen. James Jones joined the board of Invacare Corp. (NYSE:IVC), replacing departing Ohio governor-elect John Kasich effective Dec. 1.
Invacare Corp. (NYSE:IVC) CEO A. Malachi Mixon III, a name synonymous with the company since he bought it with his life savings in 1979, is stepping down from his chief executive post but will stay on as chairman.
The chief executives of healthcare companies are among the best paid in industry, according to a Wall Street Journal survey.
Boston Scientific Corp. (NYSE:BSX) CEO Raymond Elliott ranked eighth on the newspaper’s list, earning $32.1 million last year. That’s a princely sum to be sure, but includes a hefty signing bonus and other, long-term awards.
Thermo Fisher Scientific Inc. (NYSE:TMO) CEO Marc Casper edged Elliott out for the seventh spot with $33.0 million in 2009
Neoprobe Corp. (OTC:NEOP) hired a biotechnology and pharmaceuticals industry veteran as its chief development officer.
Mark Pykett, 46, is stepping into the role, which calls for him to assist the company with its product and business development, partnering and investor relations efforts, according to a press release from the Dublin, Ohio-based firm.
